Tonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan

Deep News06-30

On the evening of June 30th, Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZSE: 000766) released an announcement disclosing a planned share purchase by its leadership. The company stated that on June 25th, 2026, it received the "Drug Registration Certificate" for Succinyl Anviracetam Tablets issued by the National Medical Products Administration.

Expressing confidence in the company's future development and recognition of its long-term investment value, and aiming to further boost investor confidence while safeguarding the interests of the company and all shareholders to promote sustainable, stable, and healthy development, the company's Chairman and General Manager, Zhang Yufu, intends to increase his holdings in the company's shares within the next six months from the date of the announcement's disclosure. The planned purchase amount is no less than 10 million yuan and no more than 20 million yuan.

The announcement further revealed that prior to this planned purchase, Zhang Yufu already held 525,500 shares in the company, representing approximately 0.05% of the total share capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1149943923?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1149943923","market":"fut","top_or_hot":-1,"title":"Tonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan","media":"Deep News","content":"<p>On the evening of June 30th, <b>Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.</b> (<b>SZSE: 000766</b>) released an announcement disclosing a planned share purchase by its leadership. The company stated that on June 25th, 2026, it received the \"Drug Registration Certificate\" for Succinyl Anviracetam Tablets issued by the National Medical Products Administration.<br><br>Expressing confidence in the company's future development and recognition of its long-term investment value, and aiming to further boost investor confidence while safeguarding the interests of the company and all shareholders to promote sustainable, stable, and healthy development, the company's Chairman and General Manager, Zhang Yufu, intends to increase his holdings in the company's shares within the next six months from the date of the announcement's disclosure. The planned purchase amount is no less than 10 million yuan and no more than 20 million yuan.<br><br>The announcement further revealed that prior to this planned purchase, Zhang Yufu already held 525,500 shares in the company, representing approximately 0.05% of the total share capital.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTonghua Golden-Horse Chairman and General Manager Plans Share Purchase Worth 10 to 20 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time\">2026-06-30 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On the evening of June 30th, <b>Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd.</b> (<b>SZSE: 000766</b>) released an announcement disclosing a planned share purchase by its leadership. The company stated that on June 25th, 2026, it received the \"Drug Registration Certificate\" for Succinyl Anviracetam Tablets issued by the National Medical Products Administration.<br><br>Expressing confidence in the company's future development and recognition of its long-term investment value, and aiming to further boost investor confidence while safeguarding the interests of the company and all shareholders to promote sustainable, stable, and healthy development, the company's Chairman and General Manager, Zhang Yufu, intends to increase his holdings in the company's shares within the next six months from the date of the announcement's disclosure. The planned purchase amount is no less than 10 million yuan and no more than 20 million yuan.<br><br>The announcement further revealed that prior to this planned purchase, Zhang Yufu already held 525,500 shares in the company, representing approximately 0.05% of the total share capital.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1149943923","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1149943923","pubTimestamp":1782828079,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"On the evening of June 30th, Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZSE: 000766) released an announcement disclosing a planned share purchase by its leadership. The company stated...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0239":"医药制造","BK0077":"质押式回购","000766":"通化金马","BK0060":"抗癌"},"translate_title":"通化金马董事长兼总经理计划购买价值1000万至2000万元的股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000766":1},"content_text":"On the evening of June 30th, Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SZSE: 000766) released an announcement disclosing a planned share purchase by its leadership. The company stated that on June 25th, 2026, it received the \"Drug Registration Certificate\" for Succinyl Anviracetam Tablets issued by the National Medical Products Administration.Expressing confidence in the company's future development and recognition of its long-term investment value, and aiming to further boost investor confidence while safeguarding the interests of the company and all shareholders to promote sustainable, stable, and healthy development, the company's Chairman and General Manager, Zhang Yufu, intends to increase his holdings in the company's shares within the next six months from the date of the announcement's disclosure. The planned purchase amount is no less than 10 million yuan and no more than 20 million yuan.The announcement further revealed that prior to this planned purchase, Zhang Yufu already held 525,500 shares in the company, representing approximately 0.05% of the total share capital.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1149943923","isCrawlerRequest":true}